News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
2627282930311
2345678
9101112131415
16171819202122
23242526272829
30123456

Tuesday, November 25, 2014

Top Breaking News
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers
Actavis (ACT) Plans To Cut Jobs And Expand In China
Genentech (RHHBY) Defends Supply Shift For Top Cancer Drugs
AstraZeneca PLC (AZN), Ranbaxy Laboratories (RANBAXY.BO) Lose Bid To Derail Nexium Landmark Trial
Bayer AG (BAYZF) Continues Efforts To Sell Diabetes Device Unit
Cell Medica Rakes In $78 Million Series B To Advance Cancer Program
PROMETHERA Biosciences S.A./N.V. Raises $31.4 Million Series C
Eleven Biotherapeutics (EBIO) Scores Additional $20 Million Financing
VC Polaris Partners Raises $450M For New Health Fund
Minerva Neurosciences, Inc. (NERV) Appoints Dr. Remy Luthringer As CEO
FDA Approves Valeant (VRX)'s Onexton Gel For Acne Treatment
Mylan Inc. (MYL) Confirms First-To-File Patent Challenge Relating To BREVIBLOC
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s Rezolsta
Afferent Pharmaceuticals Clinical Data Demonstrating AF-219 Treatment Reduces Cough Frequency By 75% in Chronic Cough Is Published In The Lancet
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR

Featured Stories

More News
Janssen Research & Development Submits New Drug Application For YONDELIS (trabectedin) To U.S. FDA For The Treatment Of Patients With Advanced Soft Tissue Sarcoma
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy
R-Tech Ueno Received Orphan Drug Designation For Unoprostone Isopropyl (Development Code:UF-021) For The Treatment Of Retinitis Pigmentosa From MHLW
Intra-Cellular Therapies, Inc. Announces Enrollment Of First Patient In Phase 3 Trial Of ITI-007 For The Treatment Of Schizophrenia
Ferring Pharmaceuticals Release: New Data From A Pooled Analysis Shows Improved Overall Survival For Prostate Cancer Patients Treated With FIRMAGON® (Degarelix) Compared To LHRH Agonists
Amarantus BioSciences, Inc. Announces Positive Preclinical Data On The Effects Of MANF On Vision In A Model Of Retinitis Pigmentosa
Synthon Initiates Treatment Of First Patients In Phase I Trial Of Anti-HER2 ADC SYD985 Based On Its Proprietary Linker-Drug Platform
Antibe Therapeutics Inc. Provides Update On Its Acute Pain Drug ATB-352
Alexion Pharmaceuticals Inc. (ALXN) Release: Soliris® (Eculizumab) Granted Orphan Drug Designation In Japan For The Treatment Of Patients With Neuromyelitis Optica
Apitope Receives Orphan Designation In The European Union For ATX-F8-117 For The Treatment Of Haemophilia A
Radiological Society of North America (RSNA) Release: Asymptomatic Atherosclerosis Linked To Cognitive Impairment
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: Researchers Report Thymosin Beta 4 Is Cardioprotective In Pulmonary Hypertension/Heart Failure Model
CDC Release: Only 3 In 10 People With HIV Have The Virus In Check
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia
Parent Project Muscular Dystrophy And Santhera Pharmaceuticals AG (SANN.SW) Team Up On Benefit/Risk Study In Duchenne
Paragon Bioservices Wins NIH Contract For Design & Scale-Up Manufacturing Of rhE -Selectin Protein
University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment
Zymeworks Announces Research Collaboration With Dr. Dennis J. Slamon And University of California, Los Angeles (UCLA)
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With Pharmaceutics International, Inc.
Orgenesis Approved For EUR 2.015.000 Grant To Support Development Of Its Type 1 Diabetes Program In Europe
$750,000 Awarded To Bioo Scientific To Continue Efforts Toward Improving Small RNA-Seq Accuracy
Arena Pharmaceuticals, Inc. (ARNA) Issued Composition Of Matter Patent By United States Patent And Trademark Office For Ralinepag And Related Compounds
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Expiration Of HSR Act Waiting Period In Proposed Transaction
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc
Receptos (RCPT) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Completion Of Underwritten Public Offering Of Common Stock
Medgenics, Inc. Prices Public Offering of Common Stock
Becton, Dickinson and Company (BDX) Board Declares Dividend
Rockwell Medical (RMTI) Closes $58.5 Million Public Offering Of Common Stock
Merck & Co. (MRK) Announces Increased Quarterly Dividend
Salix Pharmaceuticals, Ltd. (SLXP) Announces Plan To Augment Board Of Directors
InVivo Therapeutics Corporation (NVIV) Announces University Of Pittsburgh Medical Center Presbyterian As New Clinical Trial Site For Neuro-Spinal Scaffold
City of Hope Researchers Unlock The Potential Of The Immune System To Fight Cancer
Sarepta Therapeutics (SRPT) To Host Webcast And Conference Call For The Duchenne Muscular Dystrophy Community On December 2, 2014
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL
Monash University Faculty Of Pharmacy And Pharmaceutical Sciences, Australia, Licenses Cresset’s Computational Tools
Pall Corporation (PLL) Reports First Quarter Results
Proteon Therapeutics, Inc. (PRTO) Announces Third Quarter 2014 Financial Results
NeoStem, Inc. CSO Dr. Robert Preti Elected Vice Chairman Of The Alliance for Regenerative Medicine (ARM)
Cellectar Biosciences  (NVLT) Names Cameron Szakacs, Ph.D. Vice President Of Clinical Development
CRF Health Boosts Leadership Team With New Appointments
Juno Therapeutics Appoints Maggie Wilderotter To Board Of Directors
Spark Therapeutics Appoints Former Chief Of U.S. FDA's Gene Therapy Branch As Its Head Of Regulatory Affairs
CytoDyn Information Now Available Through S&P Capital IQ Corporation Records Program
AlloSource Celebrates 20 Years Of Honoring The Gift Of Human Tissue Donation
EXACT Sciences Corporation (EXAS) Announces Final Payment Decision For Cologuard® From The Centers For Medicare & Medicaid Services
goBalto, Inc. Selected As A 2014 Red Herring Top 100 Global Company
USC Institute of Urology Honored Derrick Hall At "Changing Lives And Creating Cures" Gala
LabConnect, LLC Named One Of The Fastest-Growing Private Companies
Galena Biopharma  (GALE) To Present At The Oppenheimer 25th Annual Healthcare Conference
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Upcoming Investor Conferences
Upsher-Smith Laboratories To Present New Data At 2014 American Epilepsy Society Annual Meeting
Genocea Biosciences To Present At Upcoming Investor Conferences
ImmunoGen, Inc. (IMGN) Announces Clinical And Preclinical Data Presentations At Upcoming 56th American Society of Hematology Annual Meeting And Exposition
Presentations To Focus On Pluristem Therapeutics (PSTI)'s Industry-Leading Expertise In 3D Cell Culturing And Cell Expansion Technologies
Derma Sciences, Inc. (DSCI) To Participate In Two Upcoming Investor Conferences In December
Jazz Pharmaceuticals (JAZZ) Announces Participation in Two Investor Conferences
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Two Upcoming Investor Conferences
Intercept Pharmaceuticals (ICPT) To Present At Upcoming Investor Conferences
Cellular Biomedicine Group (CBMG) To Present Knee Osteoarthritis Clinical Trial Data At 2014 World Stem Cell Summit
Ignyta (RXDX) To Present At Upcoming Investor Conferences
Antares Pharma, Inc. (ATRS) To Present At The 26th Annual Piper Jaffray Healthcare Conference
Pacira Pharmaceuticals, Inc. (PCRX) To Present At The 26th Annual Piper Jaffray Healthcare Conference
BioDelivery Sciences International (BDSI) To Present At The 26th Annual Piper Jaffray Healthcare Conference
Ocata Therapeutics To Present At 26th Annual Piper Jaffray Health Care Conference
Cipher Pharmaceuticals (DND.TO) To Present At Piper Jaffray Healthcare Conference 2014
Omnicell To Present At The 26th Annual Piper Jaffray Health Care Conference
Applied Gene Technologies CEO To Present At Piper Jaffray Healthcare Conference On December 3, 2014
Lipocine Inc. (LPCN) To Present At The Piper Jaffray 26th Annual Healthcare Conference
Chimerix, Inc. (CMRX) To Present At The Piper Jaffray Healthcare Conference
Highland Therapeutics To Present At Piper Jaffray Healthcare Conference
REGENXBIO To Present At 26th Annual Piper Jaffray Healthcare Conference
Argos Therapeutics, Inc. (ARGS) To Present At The 26th Annual Piper Jaffray Healthcare Conference
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At The 26th Annual Piper Jaffray Healthcare Conference
VBL Therapeutics (VBLX) To Present Company Overview At Upcoming Conferences
Sophiris Bio Inc. (SPHS) To Present At The 26th Annual Piper Jaffray Healthcare Conference
Highland Therapeutics To Present At Piper Jaffray Healthcare Conference
Array BioPharma, Inc. (ARRY) To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences
BioLife Solutions, Inc. (BLFS.OB) To Present At The LD Micro "Main Event" Investor Conference On Wednesday, December 3, 2014
Navidea Biopharmaceuticals (NAVB) To Present At The 2014 LD Micro Conference
Advaxis, Inc. To Present At The LD Micro Conference
Codexis, Inc. (CDXS)To Present At The LD Micro Main Event VII Conference On December 4
Evoke Pharma, Inc. To Present At LD Micro Conference
TONIX Pharmaceuticals, Inc. (TNXP) To Present At The LD Micro Investor Conference
Dicerna Pharmaceuticals (DRNA) To Present At The 2014 Deutsche Bank (DB) BioFEST
Xencor To Present At The 2014 Deutsche Bank (DB) BioFEST Conference
Neurocrine Biosciences, Inc. (NBIX) To Present At The 2014 Deutsche Bank (DB) Biofest And The 26th Annual Piper Jaffray Healthcare Conference
Momenta Pharmaceuticals, Inc. (MNTA) To Webcast Presentation At 2014 Deutsche Bank (DB) BioFEST

//-->